Yuuki Ohara

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer”.

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer

Carcinogenesis(2024)10.1093/carcin/bgae056

N/A

0.439DataRank · unranked

10 citations

Yuuki Ohara, Amanda J. Craig, Huaitian Liu, S. S. Yang, Tiffany H. Dorsey +9 more

Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency

JCI Insight(2023)10.1172/jci.insight.170105

N/A

0.373DataRank · unranked

11 citations

Julián Candia, Tiffany H. Dorsey, Wei Tang, Yuuki Ohara, Jung S. Byun +14 more

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer

Cell Reports(2023)10.1016/j.celrep.2023.113434

N/A

0DataRank · unranked

37 citations

Wei Tang, Huaitian Liu, Shouhui Yang, Tiffany H. Dorsey, Helen Cawley +10 more

The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer

Trends in cancer(2022)10.1016/j.trecan.2022.03.004

N/A

0DataRank · unranked

66 citations

Paloma Valenzuela, S. Perwez Hussain, Yuuki Ohara

MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways

Carcinogenesis(2024)10.1093/carcin/bgae025

N/A

0DataRank · unranked

18 citations

Wei Tang, Azadeh Azizian, Jochen Gaedcke, Yuuki Ohara, Helen Cawley +10 more

Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients

Carcinogenesis(2022)10.1093/carcin/bgac092

N/A

0DataRank · unranked

55 citations

Wei Tang, Azadeh Azizian, Jochen Gaedcke, Philipp Ströbel, Limin Wang +11 more

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism

Carcinogenesis(2024)10.1093/carcin/bgae011

N/A

0DataRank · unranked

7 citations

Amanda J. Craig, Huaitian Liu, S. S. Yang, Paloma Moreno, Tiffany H. Dorsey +8 more